Low-dose metronomic eribulin in metastatic breast cancer: Is this real metronomic therapy?

被引：0
|
作者：
Altundag, Kadri [1 ]
机构：
[1] MKA Breast Canc Clin, Ankara, Turkey
来源：
JOURNAL OF BUON | 2021年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1174 / 1174
页数：1
相关论文
共 50 条
  • [1] Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer
    Chalasani, Pavani
    Farr, Kiah
    Wu, Vicky
    Jenkins, Isaac
    Liu, Alex
    Parker, Stephanie
    Gadi, Vijayakrishna K.
    Specht, Jennifer
    Linden, Hannah
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (01) : 91 - 99
  • [2] Metronomic eribulin in metastatic breast cancer
    Chalasani, Pavani
    Robert, Livingston B.
    Rado, Thomas A.
    Gadi, Vijayakrishna K.
    Kummet, Thomas D.
    Specht, Jennifer M.
    Stopeck, Alison
    Linden, Hannah M.
    CANCER RESEARCH, 2015, 75
  • [3] Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer
    Pavani Chalasani
    Kiah Farr
    Vicky Wu
    Isaac Jenkins
    Alex Liu
    Stephanie Parker
    Vijayakrishna K. Gadi
    Jennifer Specht
    Hannah Linden
    Breast Cancer Research and Treatment, 2021, 188 : 91 - 99
  • [4] A phase 2 study of low dose metronomic eribulin in metastatic breast cancer
    Chalasani, P.
    Liu, A. J.
    Khanjian, J. A.
    Peha, M.
    Buening, B. J.
    Gadi, V. K.
    Specht, J. M.
    Salazar, L.
    Linden, H. M.
    CANCER RESEARCH, 2019, 79 (04)
  • [5] LOW-DOSE METRONOMIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE AND METHOTREXATE IN METASTATIC BREAST CANCER PATIENTS
    Krajnak, S.
    Battista, M.
    Elger, T.
    Stewen, K.
    Heimes, A. S.
    Hasenburg, A.
    Schmidt, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 116 - 116
  • [6] LOW-DOSE METRONOMIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE AND METHOTREXATE IN METASTATIC BREAST CANCER PATIENTS
    Krajnak, S.
    Battista, M.
    Elger, T.
    Stewen, K.
    Heimes, A. S.
    Hasenburg, A.
    Schmidt, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 636 - 636
  • [7] DETERMINANTS OF THERAPEUTIC BENEFIT FROM LOW-DOSE METRONOMIC THERAPY IN HEAVILY PRETREATED METASTATIC BREAST CANCER
    Miscoria, Manuela
    Tonetto, Fabrizio
    Andreetta, Claudia
    Minisini, Alessandro
    Russo, Stefania
    Sottile, Roberta
    Mansutti, Mauro
    Fasola, Gianpiero
    Puglisi, Fabio
    ANNALS OF ONCOLOGY, 2009, 20
  • [8] Study of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer
    Kudo, Shun
    Hasunuma, Ayako
    Ahiko, Yuka
    Makino, Takatoshi
    ANNALS OF ONCOLOGY, 2015, 26 : 128 - 128
  • [9] Low-dose metronomic chemotherapy in metastatic breast cancer: A retrospective analysis of 40 patients.
    Souto, Mirela
    Shimada, Andrea
    Barbosa, Caroline Chaul
    Abrahao, Manuel Cruz
    Katz, Artur
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Low-dose metronomic gemcitabine pretreatments overcome the resistance of breast cancer to immune checkpoint therapy
    Zheng, Xichen
    Kuai, Jiajie
    Shen, Guanghui
    IMMUNOTHERAPY, 2023, 15 (06) : 429 - 442
12345